Cargando…

2821. A Comparison of Empirical Therapy with Cefazolin Versus Ceftriaxone for the Treatment of Complicated Urinary Tract Infections in a Tertiary Care VA Medical Center

BACKGROUND: Limited data exist regarding the utilization of a narrow-spectrum agent such as cefazolin for the treatment of complicated urinary tract infections (cUTIs). The objective of this study was to evaluate cefazolin compared with ceftriaxone for the empirical treatment of cUTIs in an inpatien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carcamo, Paola, Hopkins, Teri L, Yang, Linda, Frei, Christopher R, Cadena-Zuluaga, Jose, Walter, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677253/ http://dx.doi.org/10.1093/ofid/ofad500.2432

Ejemplares similares

Ceftriaxone and cefazolin attenuate the cue-primed reinstatement of alcohol-seeking
por: Weiland, Ana, et al.
Publicado: (2015)

266. Ceftriaxone Versus Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Mohamed, Adham, et al.
Publicado: (2020)

Clinical utility of methicillin-resistant Staphylococcus aureus nasal PCR to streamline antimicrobial use in treatment of diabetic foot infection with or without osteomyelitis
por: Harb, Gaielle, et al.
Publicado: (2023)

1057. Treatment Efficacy of Ceftriaxone vs. Cefazolin for Methicillin-Susceptible Staphylococcus aureus Infections
por: Bhavan, Kavita, et al.
Publicado: (2018)

101. Serious Adverse Event Rates for Cefazolin and Ceftriaxone Outpatient Parenteral Antimicrobial Therapy
por: Sunagawa, Shawnalyn, et al.
Publicado: (2023)

2133. Clinical Impact of Implementation of Rapid Diagnostic Testing of Blood Cultures on Patient Outcomes
por: Gritte, Anndee, et al.
Publicado: (2019)

Validation of Cefazolin as Initial Antibiotic for First Upper Urinary Tract Infection in Children
por: Abe, Yoshifusa, et al.
Publicado: (2016)

2262. Evaluation of Ceftriaxone Versus Cefazolin as a Surrogate Marker for Cefpodoxime Susceptibility in Enterobacterales Isolates
por: Lambert, Kaitlyn, et al.
Publicado: (2023)

1324. Identification of Local Risk Factors for P. aeruginosa in Community-acquired Pneumonia in a Veteran Population
por: Gibbons, Emily A, et al.
Publicado: (2021)

Meta-Analysis of Clinical Trials Comparing Cefazolin to Cefuroxime, Ceftriaxone, and Cefamandole for Surgical Site Infection Prevention
por: Ahmed, Nehad J., et al.
Publicado: (2022)

Significant Synergistic Effect of Peroxisome Proliferator–Activated Receptor γ C-2821T and Diabetes on the Risk of Ischemic Stroke
por: Hsieh, Fang-I, et al.
Publicado: (2009)

738. Outcomes of Ceftriaxone Versus Antistaphylococcal Penicillins or Cefazolin for Definitive Therapy of Methicillin-susceptible Staphylococcus aureus Bacteremia
por: Khodadadi, Ryan B, et al.
Publicado: (2022)

1180. Empiric treatment of uncomplicated intraabdominal infection with cefazolin with or without metronidazole
por: Borkowski, Jaime, et al.
Publicado: (2023)

1040. Comparative Characteristics of Patients With Pseudomonas Bacteremia Receiving Intravenous Only vs. Intravenous Followed by Oral Therapy
por: Vu, Trung, et al.
Publicado: (2018)

234. Dalbavancin versus Outpatient Parenteral Antimicrobial Therapy with Vancomycin for Treatment of Bone and Joint Infections in a Veteran Population
por: Gibbons, Emily A, et al.
Publicado: (2021)

850. Outcomes of Patients Discharged on Parenteral Ceftriaxone Compared with Oxacillin or Cefazolin in Methicillin-susceptible Staphylococcal aureus (MSSA) Bloodstream Infections
por: Erik Connor, Lee, et al.
Publicado: (2019)

1534. Gonorrhea Testing and Ceftriaxone Resistance in the Department of Veterans Affairs (VA), 2010-2019
por: Schirmer, Patricia, et al.
Publicado: (2020)

The Outcome of Prophylactic Intravenous Cefazolin and Ceftriaxone in Cirrhotic Patients at Different Clinical Stages of Disease after Endoscopic Interventions for Acute Variceal Hemorrhage
por: Wu, Cheng-Kun, et al.
Publicado: (2013)

165. Comparative Effectiveness of Oral Fluoroquinolones vs. β-Lactams for the Treatment of Patients with Enterobacteriaceae Bloodstream Infections
por: Bjork, Lauren, et al.
Publicado: (2019)

Semiphysiological versus Empirical Modelling of the Population Pharmacokinetics of Free and Total Cefazolin during Pregnancy
por: van Hasselt, J. G. Coen, et al.
Publicado: (2014)

730 A Retrospective Comparison of Self – Administered Ceftriaxone vs Cefazolin for Methicillin-Susceptible Staphylococcus Aureus Bacteremia in an Outpatient Antibiotic Therapy Setting.
por: Diamante, Oliver, et al.
Publicado: (2014)

Three-day ceftriaxone versus longer durations of therapy for inpatient treatment of uncomplicated urinary tract infection
por: Elajouz, Balsam, et al.
Publicado: (2022)

Comparative-Effectiveness of Oral Beta-Lactams and Fluoroquinolones for Stepdown Therapy in Patients with Enterobacterales Bloodstream Infections: A Retrospective Cohort Study
por: Bjork, Lauren, et al.
Publicado: (2023)

Corrigendum to “Semiphysiological versus Empirical Modelling of the Population Pharmacokinetics of Free and Total Cefazolin during Pregnancy”
por: van Hasselt, J. G. Coen, et al.
Publicado: (2015)

Excessive unbound cefazolin concentrations in critically ill patients receiving veno-arterial extracorporeal membrane oxygenation (vaECMO): an observational study
por: Booke, Hendrik, et al.
Publicado: (2021)

Urinary sludge caused by ceftriaxone in a young boy
por: Kimata, Takahisa, et al.
Publicado: (2012)

Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers
por: Zhou, Wei, et al.
Publicado: (2023)

The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Miller, William R, et al.
Publicado: (2018)

Cefazolin Pharmacokinetics in Premature Infants
por: Balevic, Stephen J., et al.
Publicado: (2019)

Is it just a cefazolin issue?
por: Takazawa, Tomonori, et al.
Publicado: (2019)

A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections
por: Xin, Xiaojuan, et al.
Publicado: (2013)

The Appropriateness of Empiric Treatment of Urinary Tract Infections in a Tertiary Teaching Hospital in Joran: A Cross-Sectional Study
por: Alkhawaldeh, Rama, et al.
Publicado: (2022)

Cefazolin and an aminoglycoside compared with cefazolin alone for the antimicrobial prophylaxis of type III open orthopedic fractures
por: Depcinski, Shawn C., et al.
Publicado: (2019)

Comparison the Efficacy of Cefazolin plus Gentamicin with Cefazolin plus Ciprofloxacin in Management of Type –IIIA Open Fractures
por: Janmohammadi, N, et al.
Publicado: (2011)

Cefazolin as a cause of leukocytoclastic vasculitis
por: Ali, Naveed, et al.
Publicado: (2017)

1852. Rethinking Empirical Treatment for Urinary Tract Infections in the Outpatient Setting
por: Wisnik, Christopher, et al.
Publicado: (2018)

Efficacy of Empiric Treatment of Urinary Tract Infections in Neonates and Young Infants
por: Antoon, James W., et al.
Publicado: (2019)

Cefazolin Plus Ceftazidime versus Cefazolin Monotherapy in the Treatment of Culture-Negative Peritonitis: A Retrospective Cohort Study
por: Kovitangkoon, Krit, et al.
Publicado: (2022)

The impact of biological sex on diseases of the urinary tract
por: Deltourbe, Léa, et al.
Publicado: (2022)

Empiric Usage of “Anti-Pseudomonal” Agents for Hospital-Acquired Urinary Tract Infections
por: Rahat, Ori, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vvlq6ek6dt8hbakhlo9l9svt64